nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families
|
Stadler, Zsofia K. |
|
2010 |
123 |
2 |
p. 581-585 |
artikel |
2 |
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
|
Reding, Kerryn W. |
|
2010 |
123 |
2 |
p. 491-498 |
artikel |
3 |
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival
|
Woodward, Wendy A. |
|
2010 |
123 |
2 |
p. 597-605 |
artikel |
4 |
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
|
Sharma, M. |
|
2009 |
123 |
2 |
p. 397-404 |
artikel |
5 |
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action
|
Wang, Wei |
|
2009 |
123 |
2 |
p. 321-331 |
artikel |
6 |
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer
|
Yardley, Denise |
|
2010 |
123 |
2 |
p. 471-475 |
artikel |
7 |
Association of rare MSH6 variants with familial breast cancer
|
Wasielewski, Marijke |
|
2009 |
123 |
2 |
p. 315-320 |
artikel |
8 |
BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects
|
Qiu, Li-Xin |
|
2010 |
123 |
2 |
p. 487-490 |
artikel |
9 |
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice
|
Gorczynski, Reginald M. |
|
2009 |
123 |
2 |
p. 405-415 |
artikel |
10 |
Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma
|
Erozgen, Fazilet |
|
2010 |
123 |
2 |
p. 447-452 |
artikel |
11 |
Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns
|
Gorman, Jessica R. |
|
2010 |
123 |
2 |
p. 477-485 |
artikel |
12 |
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
|
Phoenix, Kathryn N. |
|
2009 |
123 |
2 |
p. 333-344 |
artikel |
13 |
Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells
|
D’Alessio, Amelia |
|
2009 |
123 |
2 |
p. 387-396 |
artikel |
14 |
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
|
Smollich, Martin |
|
2009 |
123 |
2 |
p. 345-357 |
artikel |
15 |
Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers
|
Heerma van Voss, Marise R. |
|
2010 |
123 |
2 |
p. 611-612 |
artikel |
16 |
Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: a meta-analysis based on 24,338 cases and 60,628 controls
|
Chen, Chunhai |
|
2010 |
123 |
2 |
p. 569-576 |
artikel |
17 |
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
|
Lobo, Christopher |
|
2010 |
123 |
2 |
p. 427-435 |
artikel |
18 |
Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women’s Health Study
|
Ruiz-Narvaez, Edward A. |
|
2010 |
123 |
2 |
p. 525-530 |
artikel |
19 |
Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family
|
Diez, Orland |
|
2010 |
123 |
2 |
p. 587-590 |
artikel |
20 |
Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects
|
Qiu, Li-Xin |
|
2010 |
123 |
2 |
p. 543-547 |
artikel |
21 |
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
|
Brown, Kristy A. |
|
2010 |
123 |
2 |
p. 591-596 |
artikel |
22 |
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls
|
Qi, Xiaowei |
|
2010 |
123 |
2 |
p. 499-506 |
artikel |
23 |
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial
|
Witzel, Isabell |
|
2010 |
123 |
2 |
p. 437-445 |
artikel |
24 |
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls
|
Zhang, Jian |
|
2010 |
123 |
2 |
p. 549-555 |
artikel |
25 |
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
|
Wildiers, H. |
|
2010 |
123 |
2 |
p. 463-469 |
artikel |
26 |
NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis
|
Wang, Zhanwei |
|
2010 |
123 |
2 |
p. 557-561 |
artikel |
27 |
Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registry
|
Keegan, Theresa H. M. |
|
2010 |
123 |
2 |
p. 531-542 |
artikel |
28 |
Physical activity levels after treatment for breast cancer: one-year follow-up
|
Devoogdt, Nele |
|
2010 |
123 |
2 |
p. 417-425 |
artikel |
29 |
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study
|
Kwan, Marilyn L. |
|
2010 |
123 |
2 |
p. 507-524 |
artikel |
30 |
RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo
|
Cao, Xi-Xi |
|
2009 |
123 |
2 |
p. 375-386 |
artikel |
31 |
RAD50 gene mutations are not likely a risk factor for breast cancer in Poland
|
Mosor, Maria |
|
2010 |
123 |
2 |
p. 607-609 |
artikel |
32 |
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
|
Pritchard, Kathleen I. |
|
2010 |
123 |
2 |
p. 453-461 |
artikel |
33 |
TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects
|
Qiu, Li-Xin |
|
2010 |
123 |
2 |
p. 563-567 |
artikel |
34 |
The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects
|
Yao, Lei |
|
2010 |
123 |
2 |
p. 577-580 |
artikel |
35 |
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
|
Jin, Wei |
|
2009 |
123 |
2 |
p. 359-373 |
artikel |